Tango Therapeutics, Inc.

Insider Reports History

Location
Boston, MA
Signature
/s/ Ariel Hurley, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tango Therapeutics, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 3,400 $306,000 $90.00 08 Dec 2021 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 7,000 $105,070 $15.01 08 Dec 2021 Direct

Insider Reports Filed by Tango Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BPMC Blueprint Medicines Corp 08 Dec 2021 2 $0 4 Director 10 Dec 2021, 15:25
BPMC Blueprint Medicines Corp 08 Dec 2021 0 $0 3 Director 10 Dec 2021, 15:24